Cochrane launches global consultation on drug company sponsorship
BMJ 2003; 327 doi: https://doi.org/10.1136/bmj.327.7423.1068 (Published 06 November 2003) Cite this as: BMJ 2003;327:1068- Ray Moynihan
- Barcelona
The leadership of the international Cochrane Collaboration failed to make a decision on drug company sponsorship at last week's annual conference in Barcelona, opting instead for a complex consultation with its 10 000 members.
Professor Jim Neilson, who co-chairs the collaboration's steering group, told the BMJa discussion paper will be released next month, and a final decision will be made in February. “The members have made it very clear they want to have input into this decision.”
The Cochrane Collaboration (http://www.cochrane.org/) produces systematic reviews of the evidence about healthcare interventions, but its supporters …
Log in
Log in using your username and password
Log in through your institution
Subscribe from £173 *
Subscribe and get access to all BMJ articles, and much more.
* For online subscription
Access this article for 1 day for:
£38 / $45 / €42 (excludes VAT)
You can download a PDF version for your personal record.